Christopher Lau

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

Jordi Barretina, Barry S. Taylor, Shantanu Banerji et al. · Nature Genetics · 2010 · 726 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Prevalence, Clinicopathologic Associations, and Molecular Spectrum of <i>ERBB2</i> ( <i>HER2</i> ) Tyrosine Kinase Mutations in Lung Adenocarcinomas

Maria E. Arcila, Jamie E. Chaft, Khédoudja Nafa et al. · Clinical Cancer Research · 2012 · 498 citations · Full text

Medicine, Oncology, Pathology +17

<i>EGFR</i> Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

Maria E. Arcila, Khédoudja Nafa, Jamie E. Chaft et al. · Molecular Cancer Therapeutics · 2013 · 469 citations

Medicine, Genetics, Oncology +17

Coexistence of <i>PIK3CA</i> and Other Oncogene Mutations in Lung Adenocarcinoma–Rationale for Comprehensive Mutation Profiling

Jamie E. Chaft, Maria E. Arcila, Paul K. Paik et al. · Molecular Cancer Therapeutics · 2011 · 201 citations

Medicine, Genetics, Oncology +17

Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas

Nicolas Girard, Ronglai Shen, Tianhua Guo et al. · Clinical Cancer Research · 2009 · 193 citations · Full text

Medicine, Genetics, Oncology +17